Drug details

Cuvitru (immune globulin subcutaneous (human), 20% solution)

type of Immune Globulins

Cuvitru, Immune Globulin Subcutaneous (Human), 20% Solution is an immune globulin indicated as replacement therapy for primary humoral immunodeficiency (PI) in adult and pediatric patients two years of age and older.

This drug may have the following side effects:

• hives,
• difficulty breathing,
• swelling of your face, lips, tongue, or throat,
• severe headache,
• unusual tiredness,
• sore throat,
• fast heartbeat,
• increased sensitivity to light,
• sudden weight gain,
• changes in the amount of urine,
• stiff neck,
• persistent fever,
• yellowing of the eyes or skin (jaundice), and
• dark colored urine

The following drugs are related to Cuvitru, either as a replacement or used together:

• Combivir (lamivudine, zidovudine)
• Cutaquig (immune globulin intravenous, human)
• Videx EC (didanosine delayed-release capsules)
• Videx (didanosine pediatric powder for oral solution)
• Epivir (lamivudine)
• Epivir-HBV (lamivudine tablets and oral solution)
• Hivid (zalcitabine)
• Panzyga (immune globulin intravenous, human - ifas liquid preparation)
• Isentress (raltegravir tablets)
• Nebupent (pentamidine isethionate)
• Zerit (stavudine)